Home » Newsletters » BioWorld Science

BioWorld Science

May 5, 2006

View Archived Issues

Eltrombopag induces responses in hepatitis C patients with thrombocytopenia

Pasireotide shows potential in carcinoid tumors, acromegaly, Cushing's disease

Targeting LOX might help fight aggressive hypoxic tumors

Innogenetics and IBL Japan enter into license agreement in Alzheimer's field

Phase II evaluation of SP-01A begins second stage

Epigenetic therapy shows results in medulloblastoma in vitro experiments

GSK advances calcilytic compound from NPS collaboration

Diamyd Medical plans phase III study of Diamyd

Zonagen changes name to Repros Therapeutics

Vical's DNA vaccine protects against avian flu in animal studies

Smallpox drug candidate SIGA-246 enters phase I trials

Approvable letter for CIP-Isotretinoin

Enrollment completed in phase III trials of Nexavar in melanoma and liver cancer

FDA approves SPA for Puricase phase III trials

SPA agreement for phase III study of DG-031 for heart attack prevention

CancerVax stockholders approve merger with Micromet

XTL-2125 studied for chronic hepatitis C in new phase I trial

Encouraging phase I data for OGX-011 plus chemotherapy in NSCLC

Biogen Idec to acquire Conforma Therapeutics

Significant improvements in endpoints in integrated ambrisentan trials analysis

New higher dose formulations of Diovan HCT approved

CHMP recommends Seretide dosing for initial maintenance therapy

European approval for Tygacil

RotaTeq recommended for approval in Europe

Bioniche receives fast track designation for Urocidin

Recent patents impart new therapeutics for respiratory disorders

Novel agents for obesity and disorders of lipoprotein metabolism patented

New therapeutics for cancer covered in recent patent literature

Small alpha5beta1 integrin inhibitor reduces choroidal neovascularization in different animal models

Novel beta-tryptase inhibitor developed by Mochida

Novel antiatherothrombotic drug shows promise in preclinical studies

Preclinical data on antioxidant drugs for AMD reported by Othera

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...